Last update 01 Nov 2024
Amlodipine Besylate/Olmesartan Medoxomil/Rosuvastatin Calcium
Last update 01 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Amlodipine besylate/olmersartan medoxomil/rosuvastatin calcium, Amlodipine/olmesartan/rosuvastatin, Olmersartan medoxomil/amlodipine besilate/rosuvastatin calcium + [5] |
Mechanism AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors), VDCCs blockers(Voltage-gated calcium channel blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date KR (27 Feb 2019), |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC26H31ClN2O8S |
InChIKeyZPBWCRDSRKPIDG-UHFFFAOYSA-N |
CAS Registry111470-99-6 |
View All Structures (3)
Related
5
Clinical Trials associated with Amlodipine Besylate/Olmesartan Medoxomil/Rosuvastatin CalciumReduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia: a Multi-center-database Real-world Study
A Multi-center, Randomized, Open-label, Active-controlled, Phase IV Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab in Hypertension Patients With Low-Intermediate Risk for Cardiovascular Disease
An Open-label, Randomized, 2X2 Crossover Study to Compare the Pharmacokinetics and Safety Between DWJ1351 and Co-administration of Amlodipine/Olmesartan and Rosuvastatin in Healthy Male Subjects
100 Clinical Results associated with Amlodipine Besylate/Olmesartan Medoxomil/Rosuvastatin Calcium
Login to view more data
100 Translational Medicine associated with Amlodipine Besylate/Olmesartan Medoxomil/Rosuvastatin Calcium
Login to view more data
100 Patents (Medical) associated with Amlodipine Besylate/Olmesartan Medoxomil/Rosuvastatin Calcium
Login to view more data
100 Deals associated with Amlodipine Besylate/Olmesartan Medoxomil/Rosuvastatin Calcium
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Essential Hypertension | KR | 27 Feb 2019 | |
| Primary hypercholesterolemia | KR | 27 Feb 2019 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free